KYN -0.79% Stock Charts $KYN Kayne Anderson MLP Investment

New Waves in Pharmacy: Grant Recipients Announced In a world where pharmacy roles are ever-expanding, the American Pharmacists Association Foundation (APhA Foundation) keeps pushing boundaries. They've just announced the lucky recipients of their 2026–2027 Incentive Grants for Practitioner Innovation in Pharmaceutical Care and Improving Immunization Implementation....

Latch's Performance: A Crunch Between Software and Setbacks The stock ticker might say "LTCH," but lately, Latch Inc. is feeling more like "OUCH" for investors. While they're trumpeting a solid 18% boost in software revenue, the numbers tell a mixed story. Yeah, their software side is singing, but hardware and services took a nosedive, dragging total revenue down 18.9%...

LAE124 Could Shake Up Obesity Treatment Norms Just roll the dice on innovation sometimes, because that's when you get a spark. Laekna, a name you’ve heard in biotech circles, is gearing up to showcase LAE124 at Obesity Week 2026. This ain't just another weight-loss compound tossed into the market. We're talking about a new small-molecule dual Amylin/Calcitonin receptor...

Tyson & Mendes: A Strategic Move into the Carolinas The legal arena's always a battleground, and Tyson & Mendes just pulled off a strategic maneuver by expanding into North and South Carolina. This ain't just another firm opening more doors; it's a calculated move to fortify their defense against those monstrous Nuclear Verdicts®. You know the ones—those court...

You'll know it's a topsy-turvy market when hefty firms start switching their stock exchange allegiance. This year, nine noteworthy companies, with a collective market heft of nearly half a trillion dollars, kissed Nasdaq goodbye and nestled into the New York Stock Exchange (NYSE). Now, why would these big shots make the shift, you ask? Let's dive into the nitty-gritty....

When the reaper comes knocking, families are left juggling grief and logistics—it ain't easy. Jake Leonetti from Lewis Funeral Chapel in Bremerton, Washington, has been in the trenches long enough to know the drill. His insights might just make those funeral arrangements a bit smoother, so let's cut to the chase. First Order of Business: Contact a Funeral Director First...

The Dawn of the Agent Web Well, here we are, standing at the cusp of a new digital frontier, folks. This ain't just another buzzword parade; this is the Open Agentic Web Challenge, courting developers with a $13K carrot to craft an interoperable playground for AI agents. Big names like Cognizant AI Lab, MIT Media Lab, and others are leading the charge. No small-time...

Something's Stirring in the Renewables Sector You ever feel like the renewable energy world is moving at a breakneck pace? Well, hold onto your hat because Exus Renewables North America just secured a hefty $345 million in financing led by Goldman Sachs Alternatives. It's got "big developments" written all over it, folks. What's the Deal Here? The funds are aimed squarely...

So here we are, deep in the weeds of another utility rate hike—ain't that just the tune of the season? In Keller, Texas, homeowners are now grappling with a gas bill that's suddenly got a bit more attitude, to the tune of $13.37 more a month, thanks to Atmos Energy's fresh rate changes. I tell ya, it's enough to make you spit your morning coffee if you haven't heard the...

Sempra's Strategic Move: Simplifying or Diversifying? Well, Sempra (NYSE:SRE) just pulled the trigger on selling off a 45% stake in Sempra Infrastructure Partners (SI Partners) to KKR and the Canada Pension Plan Investment Board. It's a move wrapped in mumbo jumbo about streamlining their business. But let’s cut to the chase—what we're really seeing is a strategic...

New Insights on LEQEMBI's Impact on Alzheimer's Disease Recent clinical data reveals significant findings regarding LEQEMBI (lecanemab-irmb) and its long-term benefits for patients with early-stage Alzheimer's disease (AD). Presenting these insights at a notable conference marked a key moment for both Eisai Co., Ltd. and Biogen Inc. These findings highlight how LEQEMBI...

Valeo Shareholders' Meeting Overview Valeo is gearing up for its upcoming Combine Shareholders' Meeting, scheduled at the end of this month. Investors are eagerly anticipating this event, as it will focus on critical financial decisions and strategic directives moving forward. Key Agenda Items The meeting will commence with a review of Valeo's financial performance,...

An Overview of February's Asset Class Performance In February, global markets experienced a rally across most major asset classes, providing an intriguing backdrop for investors navigating a shifting economic landscape. While many sectors thrived, US equities struggled to maintain momentum, marking a surprising downturn. Real Estate's Standout Performance The top...

Pomerantz LLP Launches Investigation into Bitfarms Ltd. Pomerantz LLP, a respected law firm specializing in corporate and securities litigation, is currently investigating claims on behalf of investors in Bitfarms Ltd. (NASDAQ: BITF). This investigation focuses on whether there have been fraudulent activities or unlawful business practices by the company's officers and...

Centerra Gold Reports New Quarterly Dividend Centerra Gold Inc. (TSX: CG, NYSE: CGAU) has made a significant announcement regarding its financial strategy. The Board of Directors has approved a quarterly dividend of C$0.07 per common share, amounting to nearly C$14.7 million, or approximately US$10.2 million. This move demonstrates the company's commitment to providing...